吉利德科学Gilead Sciences (GILD) 2005年年度报告「NASDAQ」.pdf

1、STEPPING UP(C C)Stepping UpGILEAD SCIENCES 2005 ANNUAL REPORT Every day,we demonstrate ourREZA OLIYAI,PhD,Formulation and Process DevelopmentSTEPPING UP(1)commitment by stepping up.Stepping up,reaching for new heightsAt Gilead,we constantly ask ourselves:how can we do more?We recognizeour achievemen

2、ts to date as important steps toward our goal of advancing thecare of patients with life-threatening infectious diseases.But we retain aprofound awareness of what remains to be done.We are stepping up ourefforts across all aspects of our business innovating new therapies,increasingthe productivity o

3、f our partnerships,improving treatment options,expandingaccess to our products,assuming a greater role in addressing some of the mostcritical global health challenges and creating additional value for ourshareholders.Moving closer to our goal,by stepping up every day.In our commitment toSTEPPING UP(

4、2 3)advancing patient care.“Working as a National Accounts Manager at Gilead,I have had the opportunity to see firsthand how our therapies improve patients lives.Our commitment to patients extends beyond the innovativeproducts we offer we also establish educational programming focused onincreasing H

5、IV and HBV awareness,prevention,diagnosis,treatment and access.And by partnering with public health organizations,policy makers,community groups and payers,we can work together to truly make a difference.”care WILLIAM DOZIER,NATIONAL ACCOUNTS STEPPING UP(4 5)OUR COMMITMENT TO ADVANCING PATIENT CARE

6、Founded in 1987,Gilead Sciences is a biopharmaceuticalcompany that discovers,develops and commercializes innovative therapeutics in areas of unmet medical need.Thecompanys mission is to advance the care of patients suffering from life-threatening diseases worldwide.Gileadholds integrity,accountabili